A novel group of cross types analogues of monastrol-1,3,5-triazine were designed
A novel group of cross types analogues of monastrol-1,3,5-triazine were designed and developed one-pot synthesis using Bi(Zero3)3 being a catalyst. The search of novel therapeutic agent endowed with healing efficacy is generally an excellent concern for the Ambrisentan therapeutic chemist. At exactly the same time, the potential advancement of tolerance or level of resistance to … [Read more…]